Autor: |
Kabat AM; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom., Harrison OJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.; Immunity at Barrier Sites Initiative, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, United States., Riffelmacher T; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Moghaddam AE; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom., Pearson CF; Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom., Laing A; Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom., Abeler-Dörner L; Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom., Forman SP; Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom., Grencis RK; Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom., Sattentau Q; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom., Simon AK; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.; John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Pott J; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom., Maloy KJ; Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom. |